Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 208 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Tziomalos, Konstantinos  [Clear All Filters]
Journal Article
Bouziana, S. D., Tziomalos K., Goulas A., Vyzantiadis T-A., Panderi A., & Ηatzitolios A. Ι. (2018).  Major Adipokines and the -420C>G Resistin Gene Polymorphism as Predictors of Acute Ischemic Stroke Severity and In-Hospital Outcome.. J Stroke Cerebrovasc Dis. 27(4), 963-970.
Bouziana, S. D., & Tziomalos K. (2011).  Malnutrition in patients with acute stroke.. J Nutr Metab. 2011, 167898.
Cholongitas, E., Tziomalos K., & Pipili C. (2015).  Management of patients with hepatitis B in special populations.. World J Gastroenterol. 21(6), 1738-48.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2010).  Management of statin-intolerant high-risk patients.. Curr Vasc Pharmacol. 8(5), 632-7.
Karagiannis, A., Tziomalos K., Kakafika A. I., Athyros V. G., Harsoulis F., & Mikhailidis D. P. (2008).  Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.. Endocr Relat Cancer. 15(3), 693-700.
Mitsiou, E. K., Tziomalos K., Anagnostis P., Karagiannis A., & Athyros V. G. (2009).  Multifactorial intervention for the prevention of vascular complications of type 2 diabetes.. Hellenic J Cardiol. 50(6), 445-8.
Tziomalos, K., Athyros V. G., Paschos P., & Karagiannis A. (2015).  Nonalcoholic fatty liver disease and statins.. Metabolism. 64(10), 1215-23.
Tziomalos, K., Athyros V. G., & Karagiannis A. (2012).  Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options.. Curr Vasc Pharmacol. 10(2), 162-72.
Papagianni, M., Sofogianni A., & Tziomalos K. (2015).  Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease.. World J Hepatol. 7(4), 638-48.
Athyros, V. G., Tziomalos K., Katsiki N., & Mikhailidis D. P. (2014).  Novel data on the pathogenesis of atherosclerosis, treatment targets, and new therapeutic interventions in lipid-related cardiovascular risk factors.. Curr Pharm Des. 20(40), 6215-9.
Polychronopoulos, G., & Tziomalos K. (2017).  Novel treatment options for the management of heterozygous familial hypercholesterolemia.. Expert Rev Clin Pharmacol. 10(12), 1375-1381.
Tziomalos, K., & Dinas K. (2018).  Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome.. Front Endocrinol (Lausanne). 9, 149.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2008).  Omega-3 fatty acids: how can they be used in secondary prevention?. Curr Atheroscler Rep. 10(6), 510-7.
Pazaitou-Panayiotou, K., Iliadou P. K., Mandanas S., Vasileiadis T., Mitsakis P., Tziomalos K., et al. (2015).  Papillary thyroid carcinomas in patients under 21 years of age: clinical and histologic characteristics of tumors ≤10 mm.. J Pediatr. 166(2), 451-6.e2.
Karagiannis, A., Tziomalos K., Kakafika A., Harsoulis F., & Zamboulis C. (2004).  Paralysis as first manifestation of primary aldosteronism.. Nephrol Dial Transplant. 19(9), 2418-9.
Koiou, E., Dinas K., Tziomalos K., Toulis K., Kandaraki E. A., Kalaitzakis E., et al. (2011).  The phenotypes of polycystic ovary syndrome defined by the 1990 diagnostic criteria are associated with higher serum vaspin levels than the phenotypes introduced by the 2003 criteria.. Obes Facts. 4(2), 145-50.
Karagiannis, A., Tziomalos K., & Zamboulis C. (2004).  Plasma B-type natriuretic peptide is related to left ventricular mass in hypertensive patients.. Eur Heart J. 25(21), 1967.
Koiou, E., Tziomalos K., Dinas K., Katsikis I., Kandaraki E. A., Tsourdi E., et al. (2012).  Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome.. Endocr J. 59(1), 21-9.
Koiou, E., Tziomalos K., Katsikis I., Dinas K., Tsourdi E. A., Kandaraki E. A., et al. (2012).  Plasma von Willebrand factor antigen levels are elevated in the classic phenotypes of polycystic ovary syndrome.. Hormones (Athens). 11(1), 77-85.
Koiou, E., Tziomalos K., Katsikis I., Papadakis E., Kandaraki E. A., & Panidis D. (2013).  Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome.. Gynecol Endocrinol. 29(3), 250-3.
Athyros, V. G., Kakafika A. I., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2009).  Pleiotropic effects of statins--clinical evidence.. Curr Pharm Des. 15(5), 479-89.
Pazaitou-Panayiotou, K., Chrisoulidou A., Mandanas S., Tziomalos K., Doumala E., & Patakiouta F. (2014).  Predictive factors that influence the course of medullary thyroid carcinoma.. Int J Clin Oncol. 19(3), 445-51.
Tziomalos, K., Giampatzis V., Bouziana S., Pavlidis A., Spanou M., Papadopoulou M., et al. (2014).  Predictive value of the ankle brachial index in patients with acute ischemic stroke.. Vasa. 43(1), 55-61.
Hassapidou, M., Tzotzas T., Makri E., Pagkalos I., Kaklamanos I., Kapantais E., et al. (2017).  Prevalence and geographic variation of abdominal obesity in 7- and 9-year-old children in Greece; World Health Organization Childhood Obesity Surveillance Initiative 2010.. BMC Public Health. 17(1), 126.
Katsinelos, P., Lazaraki G., Kountouras J., Paroutoglou G., Oikonomidou I., Mimidis K., et al. (2009).  Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece.. Eur J Gastroenterol Hepatol. 21(2), 183-9.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές